The EU Probe Into Pharmaceutical Patent Settlements

Law360, New York (April 27, 2010, 12:59 PM EDT) -- Acting on the basis of its findings in a pharmaceutical sector inquiry instituted in January 2000, the European Commission recently launched investigations into patent settlements between originator and generic pharmaceutical companies.

Specifically, on Jan. 12, 2010, the Commission issued requests for information to a number of pharmaceutical companies seeking copies of their patent settlement agreements that related to the EU and were concluded between originator and generic pharmaceutical companies from July 1, 2008 to Dec. 31, 2009. (See Commission IP/10/12)

In particular, the Commission is seeking...
To view the full article, register now.

UK Financial Services

UK Financial Services

Read Our Latest UK Financial Services Coverage

Financial Services Law360 UK provides breaking news and analysis on the financial sector. Coverage includes UK and European Union policy, enforcement, and litigation involving banks, asset management firms, and other financial services organizations.